Human and large language model judgments of cognitive impairment from language: An explainable artificial intelligence approach. [PDF]
Zadok M +5 more
europepmc +1 more source
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer +14 more
wiley +1 more source
Comparison of ChatGPT-4o and expert evaluation in endodontic education: a cross-sectional pilot study. [PDF]
Alpay S +4 more
europepmc +1 more source
Exploratory Analysis of ELP1 Expression in Whole Blood From Patients With Familial Dysautonomia
ABSTRACT Background Familial dysautonomia (FD) is a hereditary neurodevelopmental disorder caused by aberrant splicing of the ELP1 gene, leading to a tissue‐specific reduction in ELP1 protein expression. Preclinical models indicate that increasing ELP1 levels can mitigate disease manifestations.
Alejandra González‐Duarte +13 more
wiley +1 more source
Developing and Validating a Global Governance Framework for Health: A Delphi Consensus Study. [PDF]
Abdel-Motaal KA, Chun S.
europepmc +1 more source
ABSTRACT Objective Peripheral neuropathies contribute to patient disability but may be diagnosed late or missed altogether due to late referral, limitation of current diagnostic methods and lack of specialized testing facilities. To address this clinical gap, we developed NeuropathAI, an interpretable deep learning–based multiclass classification ...
Chaima Ben Rabah +7 more
wiley +1 more source
Evaluating Medical Text Summaries Using Automatic Evaluation Metrics and LLM-as-a-Judge Approach: A Pilot Study. [PDF]
Vasilev Y +8 more
europepmc +1 more source
Co-Design of a New Integrated Care Model With People Affected by Huntington's Disease: A Mixed Methods Study. [PDF]
Pires SB +5 more
europepmc +1 more source
Correction to "Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers". [PDF]
europepmc +1 more source

